Responding to a growing demand in the UK for wider access to the daily contraceptive pill, England-based switch incubator Maxwellia is looking to switch the widely used progestogen only pill (POP) from prescription-only (POM) to pharmacy (P) status.
A new study has found that the increased availability and convenience of a non-prescription POP, along with rapid access to...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?